The chemical and pharmaceutical industry is under increasing pressure to complement traditional chemical catalysis with sustainable biocatalytic approaches. Enzymes enable such green chemistry. In many cases, however, they do not promote the non-natural reactions relevant for industrial processes. It thus remains a major challenge to develop novel biocatalysts for chemical reactions beyond nature’s synthetic repertoire. PhotoLanZyme addresses this problem with a fundamentally new strategy, which combines metal-dependent chemical photoredox catalysis with enzyme engineering.
Photoexcitation is a powerful catalytic trigger that facilitates single electron transfer processes inaccessible in the dark. However, the reactive radical species generated in these reactions are difficult to control, which often leads to low regio- and stereoselectivity. We propose to tackle this key challenge in synthetic chemistry by performing photoredox catalysis in de novo designed metalloproteins, which can be optimized efficiently by laboratory evolution. These proteins will not only coordinate the photocatalytic metal ion, but also provide well-defined binding interactions in a chiral environment to control reactive intermediates. Specifically, we aim to implement lanthanide-dependent photoredox chemistry in proteins, which will yield a new class of sustainable photobiocatalysts for stereoselective C–H activation and C–C bond forming reactions.